Gilead Sciences , which manufactures remdesivir, is focused on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Officer Daniel O'Day said on Friday.
), which manufactures remdesivir, is focused on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Officer Daniel O’Day said on Friday.
Gilead has already said it will donate the first 1.5 million doses of remdesivir and O’Day told NBC’s “Today” show that the company understood its responsibility to make a difference during the coronavirus pandemic. The FDA has said it was in talks with Gilead about making remdesivir available to patients as soon as possible.
Gilead’s shares were down 5.6% in early trading on Friday. The stock has risen nearly 30% in the year to date in response to the drug’s prospects as a treatment for COVID-19.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead CEO on remdesivir: manufacturing, pricing for coronavirus drug - Business InsiderGilead plans to spend up to $1 billion to ramp up manufacturing of its coronavirus treatment, but execs dodged Wall Street's questions about turning a profit
Read more »
Remdesivir maker 'moving very quickly' with FDA on possible coronavirus use, CEO saysThe company thinks it could make millions of treatment courses of remdesivir available by the end of the year if it receives FDA approval, the Gilead CEO said.
Read more »
Fauci says leak concerns fueled his White House revelation of Gilead drug resultsConcerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19.
Read more »
Stocks jump as investors weigh Gilead coronavirus treatment, GDP dataU.S. stocks rebounded Wednesday as upbeat data on coronavirus treatment from Gilead Sciences offset fresh figures that showed U.S. economic growth contracted more than expected in the first quarter.
Read more »
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
Read more »
Gilead to work with partners to ramp up production of potential coronavirus treatmentGilead Sciences Inc , maker of the closely-watched experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
Read more »